戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 y of a cohort of children from families with familial melanoma.
2 k of melanoma in patients from families with familial melanoma.
3 rder to identify other genes associated with familial melanoma.
4 chronic exposure, increases melanoma risk in familial melanoma.
5 two genes together account for a minority of familial melanoma.
6 e useful to help unravel the complexities of familial melanoma.
7 atterns of melanomas in multiple primary and familial melanomas.
8 ype 1 in the context of multiple primary and familial melanomas.
9 andom sample of 133 members of families with familial melanoma 2 to 18 years of age with variable ris
10  was 2.8 (95% CI, 2.3-3.4) for patients with familial melanoma and 2.5 (95% CI, 2.3-2.7) for patients
11  (LOD=2.54), a region already linked to both familial melanoma and ND.
12 2A loss-of-function mutations are a cause of familial melanoma and offer the opportunity to determine
13 ome mutations were identical to ones seen in familial melanoma associated with longer telomere length
14  accuracy and is acquired by the most common familial melanoma-associated CDKN2A mutation, leading to
15    These results demonstrate that particular familial melanoma-associated mutations in p16 can select
16             Here we constructed 12 different familial melanoma-associated point mutants spanning the
17 6, are responsible for a large proportion of familial melanoma cases and also increase risk of pancre
18 variants in CDKN2A account for around 40% of familial melanoma cases, and rare variants in CDK4, BRCA
19 are recurrent POT1 variants in US and French familial melanoma cases.
20 16 (CDKN2A) and p15 (CDKN2B) (encoded by the familial melanoma CDKN2 locus) inhibit CDK4/6 activity a
21  given a significantly lower prevalence in a familial melanoma cohort than in a control cohort withou
22          Notable risk in young patients with familial melanoma during first 5-year follow-up after fi
23  found a notable risk in young patients with familial melanoma during the first 5-year follow-up afte
24 ditary syndromes: basal cell nevus syndrome, familial melanoma/dysplastic nevus syndrome, and xeroder
25                                          The familial melanoma gene (INK4a/MTS1/CDKN2) encodes potent
26            So far, two genes associated with familial melanoma have been identified, accounting for a
27 that POT1 is a major susceptibility gene for familial melanoma in several populations.
28                                              Familial melanoma is an excellent human model system for
29                                              Familial melanoma is associated with point mutations in
30 thin the p16INK4a gene have been detected in familial melanoma kindreds, specific targeting of this g
31 ation that p16 was frequently inactivated in familial melanoma kindreds.
32 anoma in the context of multiple primary and familial melanomas may improve prevention, diagnosis, an
33  mutations of p16(INK4a) are associated with familial melanoma, most melanomas result from somatic ge
34                                              Familial melanoma patients are reported to present with
35                                              Familial melanoma patients develop melanomas earlier and
36 ion in melanoma cells and in the germline of familial melanoma patients.
37                                              Familial melanoma predisposition is associated with germ
38 found in melanoma tumors and associated with familial melanoma predisposition.
39                    GenoMEL, comprising major familial melanoma research groups from North America, Eu
40  Asia, and Australia has created the largest familial melanoma sample yet available to characterize m
41                     WARP was validated using familial melanoma sequence data from the European Genome
42 ted variants in MTAP, a gene adjacent to the familial melanoma susceptibility locus CDKN2A on 9p21 (r
43                   The clinical phenotypes of familial melanoma syndromes and genetic and environmenta
44                                          The familial melanoma syndromes are associated with germline
45 revalence is unknown in more common cases of familial melanoma that do not involve large families wit
46                       In the surveillance of familial melanoma, the identification of children at gre
47  the most prominent susceptibility locus for familial melanomas, the low frequency of p16 mutations i
48  second melanoma was higher in patients with familial melanoma who received a diagnosis at younger th
49 phenotype and environmental relationships in familial melanoma will likely lead to improved understan
50 focal examination, from multiple primary and familial melanomas with known CDKN2A mutational status w